{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:34:43Z","timestamp":1791214483587,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.plefa.2004.03.008","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T05:50:20Z","timestamp":1083390620000},"page":"201-204","source":"Crossref","is-referenced-by-count":161,"title":["Essential fatty acids and phospholipase A2 in autistic spectrum disorders"],"prefix":"10.1016","volume":"71","author":[{"given":"J.G.","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.E.","family":"MacKinlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.A.","family":"Glen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2004.03.008_BIB1","unstructured":"MRC Review of Autism Research, Epidemiology and Causes, Medical Research Council, London, UK, 2001, 94p."},{"key":"10.1016\/j.plefa.2004.03.008_BIB2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1362361301005001002","article-title":"The economic burden of autism in Britain","volume":"5","author":"Jarbrink","year":"2001","journal-title":"Autism"},{"key":"10.1016\/j.plefa.2004.03.008_BIB3","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","first-page":"3","article-title":"Phospholipid metabolism and the pathophysiology of psychiatric and neurological disorders","author":"Horrobin","year":"2003"},{"key":"10.1016\/j.plefa.2004.03.008_BIB4","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","first-page":"123","article-title":"Phospholipid and fatty acid biochemistry in schizophrenia","author":"Horrobin","year":"2003"},{"key":"10.1016\/j.plefa.2004.03.008_BIB5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ajcn\/62.4.761","article-title":"Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder","volume":"62","author":"Stevens","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2004.03.008_BIB6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ajcn\/71.1.327S","article-title":"Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder","volume":"71","author":"Burgess","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2004.03.008_BIB7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/plef.2000.0186","article-title":"Red blood cell fatty acid compositions in a patient with autistic spectrum disorder","volume":"63","author":"Bell","year":"2000","journal-title":"Prostag. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2004.03.008_BIB8","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","first-page":"193","article-title":"Abnormalities of fatty acid metabolism in red cells platelets and brain in schizophrenia","author":"Yao","year":"2003"},{"key":"10.1016\/j.plefa.2004.03.008_BIB9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/plef.2000.0194","article-title":"Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children","volume":"63","author":"Richardson","year":"2000","journal-title":"Prostag. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2004.03.008_BIB10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids lipid membrane abnormalities and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2004.03.008_BIB11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-1781(99)00014-1","article-title":"Lowered \u03c9 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients","volume":"85","author":"Maes","year":"1999","journal-title":"Pschiatry Res."},{"key":"10.1016\/j.plefa.2004.03.008_BIB12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0952-3278(99)80008-8","article-title":"Omega-3 fatty acids and bipolar disorder","volume":"60","author":"Stoll","year":"1999","journal-title":"Prostag. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2004.03.008_BIB13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2001.0281","article-title":"Plasma fatty acid levels in autistic children","volume":"65","author":"Vancassel","year":"2001","journal-title":"Prostag. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2004.03.008_BIB14","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","first-page":"49","article-title":"The role of plasmalogens in normal brain function and in neurological disorders","author":"Farooqui","year":"2003"},{"key":"10.1016\/j.plefa.2004.03.008_BIB15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/plef.2000.0192","article-title":"Could oxidative stress be a factor in neurodevelopmental disorders?","volume":"63","author":"Ross","year":"2000","journal-title":"Prostag. Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2004.03.008_BIB16","series-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","first-page":"183","article-title":"Cytosolic phospholipase A2 (IVPLA2) in red cells in schizophrenia and other psychiatric disorders","author":"Glen","year":"2003"},{"key":"10.1016\/j.plefa.2004.03.008_BIB17","unstructured":"M. Peet, A.I.M. Glen, D.F. Horrobin (Eds.), Phospholipid Spectrum Disorders in Psychiatry and Neurology, Marius Press, Carnforth, UK 653p. ISBN: 1-871622-25-5."},{"key":"10.1016\/j.plefa.2004.03.008_BIB18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1054\/plef.2000.0189","article-title":"Increased levels of cytosolic phospholipase A2 in dyslexics","volume":"63","author":"MacDonell","year":"2000","journal-title":"Prostag. Leukot. Essent. Fatty Acids"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T16:01:05Z","timestamp":1549728065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327804000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0952327804000572"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2004.03.008","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}